{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:45:42Z","timestamp":1778150742176,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.brainres.2024.149304","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T15:53:10Z","timestamp":1730303590000},"page":"149304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Synergistic interaction between clonidine and ACPA on the modulation of anxiety-like behaviors in non-acute restraint stress and acute restraint stress conditions"],"prefix":"10.1016","volume":"1847","author":[{"given":"Amir","family":"Chitsaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohaddeseh","family":"Ebrahimi-Ghiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad-Reza","family":"Zarrindast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7395-9974","authenticated-orcid":false,"given":"Fatemeh","family":"Khakpai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2024.149304_b0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-2999(02)01493-0","article-title":"Effect of cannabinoids on synaptic transmission in the rat hippocampal slice is temperature-dependent","volume":"442","author":"Al-Hayani","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2024.149304_b0010","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/pan.14279","article-title":"Preoperative anxiety in preschool children: a randomized clinical trial comparing midazolam, clonidine, and dexmedetomidine","volume":"31","author":"Bromfalk","year":"2021","journal-title":"Pediatr. Anesth."},{"key":"10.1016\/j.brainres.2024.149304_b0015","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1213\/00000539-199111000-00021","article-title":"Adrenergic modulation of preoperative anxiety: a comparison of temazepam, clonidine, and timolol","volume":"73","author":"Carabine","year":"1991","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.brainres.2024.149304_b0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pnpbp.2012.01.008","article-title":"Cannabinoid modulation of noradrenergic circuits: implications for psychiatric disorders","volume":"38","author":"Carvalho","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2024.149304_b0025","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1111\/ejn.12690","article-title":"Cannabinoid modulation of alpha2 adrenergic receptor function in rodent medial prefrontal cortex","volume":"40","author":"Cathel","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2024.149304_b0030","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pnpbp.2012.05.018","article-title":"Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex","volume":"39","author":"Chiba","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2024.149304_b0035","article-title":"Cannabinoids for the treatment of schizophrenia? A balanced neurochemical framework for both adverse and therapeutic effects of cannabis use","volume":"2011","author":"Coulston","year":"2011","journal-title":"Schizophr. Res. Treat."},{"key":"10.1016\/j.brainres.2024.149304_b0040","doi-asserted-by":"crossref","unstructured":"Davis, J.A., 2008. Mouse and rat anesthesia and analgesia. Current protocols in neuroscience. 42, A. 4B. 1-A. 4B. 21.","DOI":"10.1002\/0471142301.nsa04bs42"},{"key":"10.1016\/j.brainres.2024.149304_b0045","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/605914","article-title":"Xiao Yao San improves depressive-like behaviors in rats with chronic immobilization stress through modulation of locus coeruleus-norepinephrine system","volume":"2014","author":"Ding","year":"2014","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.brainres.2024.149304_b0050","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pnpbp.2011.12.010","article-title":"Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase","volume":"38","author":"Fi\u0161ar","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2024.149304_b0055","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1037\/a0023165","article-title":"Molecular modulation of prefrontal cortex: rational development of treatments for psychiatric disorders","volume":"125","author":"Gamo","year":"2011","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.brainres.2024.149304_b0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2344\/0003-3006-62.1.31","article-title":"Alpha-2 adrenergic receptor agonists: a review of current clinical applications","volume":"62","author":"Giovannitti","year":"2015","journal-title":"Anesth. Prog."},{"key":"10.1016\/j.brainres.2024.149304_b0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0165-1781(97)00041-3","article-title":"Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls","volume":"71","author":"Gurguis","year":"1997","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.brainres.2024.149304_b0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2344\/0003-3006(2006)53[34:OCPPTV]2.0.CO;2","article-title":"Oral clonidine pretreatment prior to venous cannulation","volume":"53","author":"Hall","year":"2006","journal-title":"Anesth. Prog."},{"key":"10.1016\/j.brainres.2024.149304_b0075","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1038\/s41380-020-0685-9","article-title":"Prefrontal cortex circuits in depression and anxiety: contribution of discrete neuronal populations and target regions","volume":"25","author":"Hare","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2024.149304_b0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuroscience.2011.12.035","article-title":"Neuronal populations mediating the effects of endocannabinoids on stress and emotionality","volume":"204","author":"H\u00e4ring","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2024.149304_b0085","doi-asserted-by":"crossref","first-page":"e0158950","DOI":"10.1371\/journal.pone.0158950","article-title":"Putative epigenetic involvement of the endocannabinoid system in anxiety-and depression-related behaviors caused by nicotine as a stressor","volume":"11","author":"Hayase","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2024.149304_b0090","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tips.2009.06.006","article-title":"The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants","volume":"30","author":"Hill","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.brainres.2024.149304_b0095","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/archpsyc.1981.01780360094011","article-title":"Effects of clonidine on anxiety disorders","volume":"38","author":"Hoehn-Saric","year":"1981","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.brainres.2024.149304_b0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.tips.2009.10.003","article-title":"Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders-the case of yohimbine","volume":"31","author":"Holmes","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.brainres.2024.149304_b0105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/0269881109359099","article-title":"Noradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challenge","volume":"25","author":"Hood","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.brainres.2024.149304_b0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.irn.2020.11.014","article-title":"Medial prefrontal cortex encoding of stress and anxiety","volume":"158","author":"Jacobs","year":"2021","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.brainres.2024.149304_b0115","first-page":"613","article-title":"The effect of BLA GABA(A) receptors in anxiolytic-like effect and aversive memory deficit induced by ACPA","volume":"14","author":"Kangarlu-Haghighi","year":"2015","journal-title":"EXCLI J."},{"key":"10.1016\/j.brainres.2024.149304_b0120","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainres.2024.149304_b0125","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.2147\/NDT.S167538","article-title":"Addictive potential of novel treatments for refractory depression and anxiety","volume":"14","author":"Kolar","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.brainres.2024.149304_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2023.100537","article-title":"Poststress social isolation exerts anxiolytic effects by activating the ventral dentate gyrus","volume":"24","author":"Lei","year":"2023","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.brainres.2024.149304_b0135","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuroimage.2004.08.016","article-title":"A direct brainstem-amygdala-cortical 'alarm' system for subliminal signals of fear","volume":"24","author":"Liddell","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.brainres.2024.149304_b0140","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nrn2639","article-title":"Effects of stress throughout the lifespan on the brain, behaviour and cognition","volume":"10","author":"Lupien","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2024.149304_b0145","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neuroscience.2011.07.052","article-title":"Cannabinoids and emotionality: a neuroanatomical perspective","volume":"204","author":"McLaughlin","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2024.149304_b0150","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/FBP.0b013e32832c70b1","article-title":"Interactions between the anxiogenic effects of CB1 gene disruption and 5-HT3 neurotransmission","volume":"20","author":"Mikics","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.brainres.2024.149304_b0155","first-page":"1","article-title":"Synergistic antidepressant- and anxiolytic-like effects of harmaline along with cinanserin in acute restraint stress-treated mice","author":"Mosaffa","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2024.149304_b0160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2006.09.110","article-title":"Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex","volume":"1127","author":"Oropeza","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2024.149304_b0165","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pbb.2006.12.020","article-title":"Repeated cannabinoid administration increases indices of noradrenergic activity in rats","volume":"86","author":"Page","year":"2007","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.brainres.2024.149304_b0170","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/978-3-540-88955-7_14","article-title":"Role of endocannabinoid signaling in anxiety and depression","volume":"1","author":"Patel","year":"2009","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.brainres.2024.149304_b0175","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.brainres.2024.149304_b0180","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/10253890.2011.586753","article-title":"Endocannabinoids and stress","volume":"14","author":"Riebe","year":"2011","journal-title":"Stress"},{"key":"10.1016\/j.brainres.2024.149304_b0185","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1046\/j.1460-9568.2003.02548.x","article-title":"\u2018One-trial sensitization\u2019to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze","volume":"17","author":"Rodgers","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.brainres.2024.149304_b0190","first-page":"S7","article-title":"Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?","volume":"32","author":"Saito","year":"2010","journal-title":"Braz J Psychiatry."},{"key":"10.1016\/j.brainres.2024.149304_b0195","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1176\/appi.ajp.157.8.1236","article-title":"Yohimbine challenge in children with anxiety disorders","volume":"157","author":"Sallee","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainres.2024.149304_b0200","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1523\/JNEUROSCI.21-13-04875.2001","article-title":"The \u03b12A-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety","volume":"21","author":"Schramm","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2024.149304_b0205","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/npr2.12093","article-title":"Differential effects of stress exposure via two types of restraint apparatuses on behavior and plasma corticosterone level in inbred male BALB\/cAJcl mice","volume":"40","author":"Shoji","year":"2020","journal-title":"Neuropsychopharmacol Rep."},{"key":"10.1016\/j.brainres.2024.149304_b0210","doi-asserted-by":"crossref","first-page":"462","DOI":"10.2174\/1570159X12666140923205412","article-title":"The endocannabinoid\/endovanilloid system and depression","volume":"12","author":"Smaga","year":"2014","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.brainres.2024.149304_b0215","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.biopsych.2013.10.008","article-title":"Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial","volume":"75","author":"Smits","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2024.149304_b0220","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.tpj.6500466","article-title":"Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice","volume":"8","author":"Steiner","year":"2008","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.brainres.2024.149304_b0225","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0006-3223(01)01292-6","article-title":"Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients","volume":"51","author":"Stine","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2024.149304_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3897\/pharmacia.71.e115659","article-title":"The endogenous cannabinoid and the adrenergic systems in modulation of stress-response","volume":"71","author":"Suleymanoglu","year":"2024","journal-title":"Pharmacia."},{"key":"10.1016\/j.brainres.2024.149304_b0235","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3389\/fnins.2017.00243","article-title":"Effects of alpha2A adrenoceptors on norepinephrine secretion from the locus coeruleus during chronic stress-induced depression","volume":"11","author":"Wang","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.brainres.2024.149304_b0240","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00008877-200509000-00005","article-title":"A role for cannabinoid CB1 receptors in mood and anxiety disorders","volume":"16","author":"Witkin","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.brainres.2024.149304_b0245","first-page":"742","article-title":"Reduction of anxiety after treatment with transdermal clonidine","volume":"75","author":"Ye","year":"2018","journal-title":"The Bulletin of the American Society of Hospital Pharmacists."},{"key":"10.1016\/j.brainres.2024.149304_b0250","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/FBP.0b013e3283123c83","article-title":"Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system","volume":"19","author":"Zarrindast","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.brainres.2024.149304_b0255","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/0269881110376688","article-title":"Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems","volume":"25","author":"Zarrindast","year":"2011","journal-title":"J. Psychopharmacol."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899324005584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899324005584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:34:41Z","timestamp":1760823281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899324005584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":51,"alternative-id":["S0006899324005584"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2024.149304","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic interaction between clonidine and ACPA on the modulation of anxiety-like behaviors in non-acute restraint stress and acute restraint stress conditions","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2024.149304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149304"}}